KRYS Sale Disclosure
Krishnan Suma · SEC Form 4 · Filed Sep 4, 2026
Sale
Calculated transaction value
$836.28K
Krishnan Suma President, R&d
KRYS
Krystal Biotech
KRYS
Transaction date
Sep 4, 2026
Public filing date
Sep 4, 2026
Filing lag
Filed same day
KRYS daily price context
Close on/before transaction
$358.24
Sep 4, 2026
Close before public filing
$371.47
Sep 3, 2026
Return since public filing
-9.24%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,320 shares @ $360.47
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001298711-26-000009
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$8.98M
Buys / sales
0 / 13
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.42M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $449.12K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $484.39K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $205.29K |
| Krystal Biotech, Inc. KRYS Current | Sale | Sep 4, 2026 | $836.28K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $146.26K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $184.36K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $722.4K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.16M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $301.83K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $713.28K |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.14M |
| Krystal Biotech, Inc. KRYS | Sale | Sep 4, 2026 | $1.22M |